Derm SAQs ·
Immune checkpoint inhibitor-related dermatologic adverse events. — SAQ
On this page
Study tools
Prompt
Write your answer
Saved on this device. No marking — you are the marker.
Stem
A patient presents with features suggestive of immune checkpoint inhibitor-related dermatologic adverse events.. Phototherapy uses ultraviolet light to treat skin disease. Narrowband UVB (nbUVB) 311-313 nm = first-line phototherapy for psoriasis, atopic dermatitis, vitiligo; *safe in pregnancy and children...
Questions
a) What is the most likely diagnosis and what clinical features support it? (2 marks)
b) What investigations would you arrange to confirm the diagnosis? (3 marks)
c) Outline your management plan for this patient. (3 marks)
d) What are the key complications and prognostic factors? (2 marks)